Drug Information Association Logo

Hot Topics: Innovations in Medical Communications

Track:
Medical Communications

Day & Time:
March 11, 10:30AM - 12:00PM

Room Number:
Ballroom Salon G

Type:
Session

Title:
Hot Topics: Innovations in Medical Communications

Chair(s):
Poonam A. Bordoloi, PharmD
SeniorManager, Medical Information Services Internal Medicine and BioSurgery
Sanofi, United States

Description:
This interactive session will review several hot topics of interest to Medical Information (MI) professionals. Have you ever wondered how other companies respond to ingredient and complex formulation questions? How is all the information organized and how much detail is provided to the customer by the contact center or the MI specialist? What about the open-space concept? Several companies are trending towards open workspace including MI groups. Does this really work?

In January, the FDA issued draft guidance providing us with yet another glimpse of how social media and online promotion come together. The new guidance is titled: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal and Drugs and Biologics. How will this guidance affect the responsibilities and activities specific to MI groups? What about devices? We are sure this topic will generate some great dialogue.

During this session, you will have the opportunity to hear from a distinguished panel of experienced Medical Communications professionals and have the opportunity to share best practices. You are invited to attend and participate in a lively discussion that will leave you with great ideas to think about when you return back to your “workspace”.

Learning Objective(s):
At the conclusion of this session, participants should be able to:
Define key documents and contacts required to create appropriate standard response documents for complex ingredient and formulation questions
Evaluate and assess the types of responses provided to healthcare professionals and consumers
Compare and contrast the positives and negatives of the open workspace concept
Assess the recently issued FDA draft guidance and discuss the use of interactive technologies

Presentation(s) & Speaker(s):
Hot Topics: Innovations in Medical Communications
Juan C. Nadal, MD
Vice President Medical Communications, Medical Affairs
Bayer HealthCare Pharmaceuticals, United States

Hot Topics: Innovations in Medical Communications
Thomas Faria, PharmD
Senior Director, Global Medical Information
Celgene Corporation, United States

Hot Topics: Innovations in Medical Communications
Robert A Lewis, PharmD
Director, Medical Information
Regeneron Pharmaceuticals, Inc., United States

© 2014 DIA